Edition:
India

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

13.05USD
17 Aug 2018
Change (% chg)

$0.08 (+0.62%)
Prev Close
$12.97
Open
$12.83
Day's High
$13.05
Day's Low
$12.83
Volume
5,079
Avg. Vol
5,093
52-wk High
$15.75
52-wk Low
$5.48

Chart for

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $70.42
Shares Outstanding(Mil.): 9.71
Dividend: --
Yield (%): --

Financials

  KALV.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -3.21 -- --
ROI: -60.80 15.07 14.61
ROE: -61.05 16.59 16.33

Earnings vs. Estimates